Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossMedicare Advantage · Billing Codes · Medical Policy · Orthopedics, Rheumatology, Pain Management +2 moreMedium impact

MA11.023l, Hyaluronan Therapies for Osteoarthritis of the Knee

Act
by Dec 1, 2025
Effective date
Dec 1, 2025
Identified
Jun 19, 2026

Summary

Independence Blue Cross updated MA policy MA11.023l to MA11.023m effective 12/01/2025, aligning hyaluronan therapy coverage with FDA labeling and Novitas LCD L35529 recommendations. Four unspecified laterality diagnosis codes (M17.10, M17.30, M17.5, M17.9) were removed from the approved coding table, requiring claims to use only laterality-specific codes going forward.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

by Dec 1, 2025 · 5 steps
01Billing team must immediately update billing system and claim submission workflows to REMOVE unspecified laterality diagnosis codes M17.10, M17.30, M17.5, and M17.9 from hyaluronan injection claims for Independence Blue Cross Medicare Advantage members.
02Claims must now use ONLY laterality-specific codes: M17.11 (right knee) or M17.12 (left knee) for primary osteoarthritis, M17.31 (right) or M17.32 (left) for post-traumatic osteoarthritis, or M17.0 (bilateral primary) or M17.2 (bilateral post-traumatic) when applicable.
03Update prior authorization templates, encounter forms, and billing software validation rules to enforce laterality coding requirements.
04Notify all providers of the change.
05Claims submitted with deprecated unspecified codes after the effective date will be denied and require resubmission with corrected laterality-specific codes.

Codes mentioned

J7318J7320J7321J7322J7323J7324J7325M17.0M17.11M17.12M17.2M17.31M17.32M17.4

Original notice

MA11.023l, Hyaluronan Therapies for Osteoarthritis of the Knee
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related changes

See all Independence Blue Cross changes →
MA11.023m, Hyaluronan Therapies for Osteoarthritis of the KneeLowEffective Jan 2, 2026 · Medical Policy11.14.07y, Intra-Articular Injection of Hyaluronan for the Treatment of OsteoarthritisHighEffective Dec 1, 2025 · PharmacyMA05.070, Apos® biomechanical shoe systemLowEffective Jan 1, 2024 · PharmacyMA08.097a, Triamcinolone Acetonide ER Injectable (Zilretta®)LowEffective Apr 1, 2026 · PharmacyBrowse every Independence Blue Cross change in the policy list

Related policy hubs

Independence Blue Cross policiesOrthopedicsRheumatologyPain ManagementSports MedicinePM&R (Physical Medicine & Rehab)Code J7318Code J7320Code J7321Code J7322Code J7323Code J7324Code J7325Code M17.0Code M17.11Code M17.12Code M17.2Code M17.31Code M17.32Code M17.4

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account